This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Kerubo G, Khamadi S, Okoth V, Madise N, Ezeh A, Abdalla Z, et al. Hepatitis B, hepatitis C and HIV-1 coinfection in two informal urban settlements in Nairobi, Kenya. PLoS One. 2015; 10:e0129247.2606821210.1371/journal.pone.0129247KeruboGKhamadiSOkothVMadiseNEzehAAbdallaZet alHepatitis B, hepatitis C and HIV-1 coinfection in two informal urban settlements in Nairobi, KenyaPLoS One201510e0129247446631426068212Search in Google Scholar
Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China. Arch Virol. 2013; 158: 1889-94.2355345410.1007/s00705-013-1681-zChenXHeJMDingLSZhangGQZouXBZhengJ.Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central ChinaArch Virol201315818899423553454Search in Google Scholar
Akekawatchai C, Sretapunya W, Pipatsatitpong D, Chuenchit T. Risks for transaminitis in Thais coinfected with human immunodeficiency virus and hepatitis B or C virus on combined antiretroviral therapy. Asian Biomed. 2015; 9:353-61.AkekawatchaiCSretapunyaWPipatsatitpongDChuenchitT.Risks for transaminitis in Thais coinfected with human immunodeficiency virus and hepatitis B or C virus on combined antiretroviral therapyAsian Biomed2015935361Search in Google Scholar
Cooper CL, Parbhakar MA, Angel JB. Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis. 2002; 34: 1259.10.1086/33986711941553CooperCLParbhakarMAAngelJB.Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virusClin Infect Dis200234125911941553Open DOISearch in Google Scholar
Pineda JA, Romero-Gomez M, Diaz-Garcia F, Giron-Gonzalez JA, Montero JL, Torre-Cisneros J, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology. 2005; 41:779-89.1580095610.1002/hep.20626PinedaJARomero-GomezMDiaz-GarciaFGiron-GonzalezJAMonteroJLTorre-CisnerosJet alHIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosisHepatology2005417798915800956Search in Google Scholar
Eskild A, Magnus P, Petersen G, Sohlberg C, Jensen F, Kittelsen P, et al. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS. 1992; 6:571.EskildAMagnusPPetersenGSohlbergCJensenFKittelsenPet alHepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDSAIDS1992657110.1097/00002030-199206000-000081388879Search in Google Scholar
Liaw YF. Impact of therapy on the outcome of chronic hepatitis B. Liver Int. 2013; 33 (Suppl 1):111-5.10.1111/liv.1205723286854LiawYFImpact of therapy on the outcome of chronic hepatitis BLiver Int201333Suppl 1111523286854Open DOISearch in Google Scholar
Gutierrez JA, Lawitz EJ, Poordad F. Interferon-free, direct-acting antiviral therapy for chronic hepatitis C. J Viral Hepat. 2015 Jun 17. doi: 10.1111/jvh.12422. [Epub ahead of print]GutierrezJALawitzEJPoordadF.Interferon-free, direct-acting antiviral therapy for chronic hepatitis CJ Viral Hepat2015Jun17doi:10.1111/jvh.12422[Epub ahead of print]Open DOISearch in Google Scholar
Marciano S, Galdame OA, Barcan LA, Gadano AC. Successful treatment with telaprevir of post-transplant fibrosing cholestatic hepatitis C in an HIV co-infected patient. Acta Gastroenterol Latinoam. 2015; 45:76-9.MarcianoSGaldameOABarcanLAGadanoAC.Successful treatment with telaprevir of post-transplant fibrosing cholestatic hepatitis C in an HIV co-infected patientActa Gastroenterol Latinoam201545769Search in Google Scholar
CDC Sexually Transmitted Diseases Treatment Guidelines, 2010. Morbidity and mortality weekly report recommendations and reports. 2010; 59.CDC Sexually Transmitted Diseases Treatment Guidelines, 2010Morbidity and mortality weekly report recommendations and reports201059Search in Google Scholar
